Centene Corporation (NYSE: CNC) is one of 14 public companies in the “Managed Health Care” industry, but how does it compare to its peers? We will compare Centene Corporation to related companies based on the strength of its profitability, valuation, analyst recommendations, dividends, earnings, institutional ownership and risk.

Valuation & Earnings

This table compares Centene Corporation and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Centene Corporation $43.65 billion $2.19 billion 19.90
Centene Corporation Competitors $52.30 billion $3.74 billion 17.32

Centene Corporation’s peers have higher revenue and earnings than Centene Corporation. Centene Corporation is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings and price targets for Centene Corporation and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene Corporation 1 4 12 0 2.65
Centene Corporation Competitors 79 865 1416 22 2.58

Centene Corporation presently has a consensus target price of $93.38, indicating a potential upside of 3.11%. As a group, “Managed Health Care” companies have a potential upside of 2.99%. Given Centene Corporation’s stronger consensus rating and higher probable upside, research analysts plainly believe Centene Corporation is more favorable than its peers.

Profitability

This table compares Centene Corporation and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Centene Corporation 1.72% 14.62% 4.24%
Centene Corporation Competitors 1.70% 10.53% 3.41%

Insider & Institutional Ownership

92.4% of Centene Corporation shares are owned by institutional investors. Comparatively, 90.2% of shares of all “Managed Health Care” companies are owned by institutional investors. 3.0% of Centene Corporation shares are owned by insiders. Comparatively, 2.4% of shares of all “Managed Health Care” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Centene Corporation has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Centene Corporation’s peers have a beta of 0.76, meaning that their average stock price is 24% less volatile than the S&P 500.

Summary

Centene Corporation beats its peers on 9 of the 13 factors compared.

About Centene Corporation

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.

Receive News & Ratings for Centene Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene Corporation and related companies with MarketBeat.com's FREE daily email newsletter.